About Tokyo Medical University Hachioji Medical Center
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
AM-Pharma
1
Gilead Sciences
1
Clinical Trials at Tokyo Medical University Hachioji Medical Center
During the past decade, Tokyo Medical University Hachioji Medical Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Have an Inadequate Response or Are Intolerant to Biologic DMARD Therapy
(Revival) Study to Investigate the Efficacy and Safety of Alkaline Phosphatase in Patients With Sepsis-Associated AKI
2020-11-02
2022-08-18
Terminated
661
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Tokyo Medical University Hachioji Medical Center"
#1 collaborator was "Galapagos NV" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Tokyo Medical University Hachioji Medical Center
According to Clinical.Site data, the most researched conditions in "Tokyo Medical University Hachioji Medical Center" are
"Acute Kidney Injury Due to Sepsis" (1 trials) and "Psoriatic Arthritis" (1 trials). Many other conditions were trialed in "Tokyo Medical University Hachioji Medical Center" in a lesser frequency.
Clinical Trials Intervention Types at Tokyo Medical University Hachioji Medical Center
Most popular intervention types in "Tokyo Medical University Hachioji Medical Center" are "Biological" (1 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Filgotinib" (1 trials), "Placebo" (1 trials), "Placebo to match filgotinib" (1 trials) and "Recombinant human alkaline phosphatase" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Tokyo Medical University Hachioji Medical Center
The vast majority of trials in "Tokyo Medical University Hachioji Medical Center" are
2 trials for "All" genders.
Clinical Trials Status at Tokyo Medical University Hachioji Medical Center
Currently, there are NaN active trials in "Tokyo Medical University Hachioji Medical Center".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Tokyo Medical University Hachioji Medical Center,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Tokyo Medical University Hachioji Medical Center, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".